Integrated microplate platform for epigenetic analysis
用于表观遗传分析的集成微孔板平台
基本信息
- 批准号:8754755
- 负责人:
- 金额:$ 23.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:Animal Disease ModelsAntibodiesArchivesAreaAutomationBindingBiochemistryBiological AssayBiological MarkersBiologyBiotechnologyCell CountCell Culture TechniquesCell NucleusCellsCellular biologyChromatinClinicalComplexDNADNA Modification ProcessDNA analysisDNA purificationDNA-Protein InteractionData AnalysesDetectionDiagnosisDiseaseEngineeringEnvironmentEnzymesEpigenetic ProcessEpitopesEventFunctional disorderGene ExpressionGenesGenetic TranscriptionGenomicsGoalsHarvestHistonesHumanImageryImmunoprecipitationInterventionKnowledgeMediatingMethodsModificationMolecular BiologyMutationNucleosomesPharmaceutical PreparationsPositioning AttributePrecipitationPreparationProceduresProcessProtein BindingProteinsRNA ProcessingReproducibilityResolutionRoboticsRunningSamplingSignal TransductionStructureSurfaceSystemTechniquesTechnologyTestingTimeTissuesTranscription ProcessTranslational ResearchTubeUltrasonographyVariantWorkbasecell typechromatin immunoprecipitationchromatin modificationclinical applicationcomputerized toolsepigenetic markerextracellularfield studyhigh throughput technologyhistone modificationhuman embryonic stem cellimprovedinnovationinstrumentationinterdisciplinary approachinterestnew technologynovelpluripotencyprogramspublic health relevancereceptorresponsesmall moleculestem cell divisiontooltranscription factoruser-friendly
项目摘要
DESCRIPTION (provided by applicant): Epigenetic processes interpret the genomic sequences in a cell-type and extracellular environment-dictated mode. Epigenetic information is encoded through covalent modifications of histones and DNA, nucleosome position and substitution by histone variants. Epigenetics is one of the most intensively studied fields of biology today and represents a new paradigm for the pathophysiology, diagnosis and treatment of diseases. To advance epigenetic studies, we have introduced a novel chromatin immunoprecipitation platform, Matrix ChIP, that utilizes surface-immobilized antibodies in a 96-well plate, where the entire procedure from chromatin precipitation to PCR-ready DNA purification is done on the same plate without sample transfers. This high- throughput method allows for parallel profiling of an order of magnitude greater number of chromatin and transcription events than was previously possible. Matrix ChIP is more sensitive than traditional approach to detect DNA-protein interactions of less abundant proteins such as chromatin modifiers. ChIP assay consists of three separate steps: (1) sample harvesting/chromatin fragmentation, (2) immunoprecipitation and (3) DNA purification and analysis (qPCR/sequencing). Although in the Matrix ChIP, steps (2) and (3) are greatly simplified allowing one to run hundreds of assays at a time, sample harvesting/chromatin fragmentation is done in test tubes with low efficiency and high labor intensity. This project proposes an innovative multidisciplinary approach (Dr. Matula, ultrasound/engineering, Dr. Denisenko, molecular biology, and Dr. Bomsztyk, chromatin biology/biotechnology/instrumentation) to develop a platform, PIXUL-ChIP, that will integrate highly efficient sample harvesting and chromatin shearing with immunoprecipitation in microplates for high-throughput epigenetic analysis. The following aims are proposed. Aim#1. To build a pixelated ultrasound (PIXUL) processor for high-throughput fast chromatin shearing. Aim#2. To combine sample harvesting and chromatin shearing with immunoprecipitation into an integrated microplate platform for epigenetic analysis, PIXUL-ChIP. Aim#3. To test PIXUL-ChIP as a platform for studies of epigenetic changes at selected gene loci associated with drug-mediated human embryonic stem cell (hESC) renewal and differentiation. Epigenetics is a fast growing field, but nonetheless, there are significant unmet needs that require further technological advances to facilitate exploration of epigenetic processes and exploit this knowledge in translational research and clinical applications. A highly efficient technology, PIXUL-ChIP will provide powerful means to simultaneously study multiple chromatin modifications and modifiers at gene loci in a wide range of systems, and as such will be a valuable platform for studying epigenetic processes, discovering epigenetic biomarkers, and testing novel drugs and their combinations.
描述(由申请人提供):表观遗传过程以细胞类型和细胞外环境决定的模式解释基因组序列。表观遗传信息通过组蛋白和DNA的共价修饰、核小体位置和组蛋白变体的取代来编码。表观遗传学是当今生物学研究最深入的领域之一,代表了疾病病理生理学、诊断和治疗的新范式。为了推进表观遗传学研究,我们引入了一种新的染色质免疫沉淀平台Matrix ChIP,该平台在96孔板中利用表面固定的抗体,其中从染色质沉淀到PCR就绪的DNA纯化的整个过程在同一板上完成,而无需样品转移。这种高通量方法允许平行分析比以前可能的数量级更大的染色质和转录事件。Matrix ChIP比传统方法更灵敏地检测不太丰富的蛋白质如染色质修饰剂的DNA-蛋白质相互作用。ChIP测定由三个单独的步骤组成:(1)样品收获/染色质片段化,(2)免疫沉淀和(3)DNA纯化和分析(qPCR/测序)。虽然在Matrix ChIP中,步骤(2)和(3)被大大简化,允许一次运行数百个检测,但样品收获/染色质片段化是在试管中完成的,效率低,劳动强度高。该项目提出了一种创新的多学科方法(Matula博士,超声/工程,Denisenko博士,分子生物学和Bomsztyk博士,染色质生物学/生物技术/仪器)来开发一个平台PIXUL-ChIP,该平台将高效的样品采集和染色质剪切与微孔板中的免疫沉淀相结合,用于高通量表观遗传分析。提出了以下目标。目标1。构建一个用于高通量快速染色质剪切的像素化超声(PIXUL)处理器。目标2。将联合收割机样品收获和染色质剪切与免疫沉淀结合到用于表观遗传分析的集成微孔板平台PIXUL-ChIP中。目标3。测试PIXUL-ChIP作为研究与药物介导的人胚胎干细胞(hESC)更新和分化相关的选定基因位点表观遗传学变化的平台。表观遗传学是一个快速发展的领域,但尽管如此,仍然存在重大的未满足的需求,需要进一步的技术进步,以促进对表观遗传过程的探索,并在转化研究和临床应用中利用这些知识。PIXUL-ChIP是一种高效的技术,将为在广泛的系统中同时研究基因位点的多种染色质修饰和修饰剂提供强有力的手段,因此将成为研究表观遗传过程、发现表观遗传生物标志物和测试新药及其组合的有价值的平台。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
                item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ patent.updateTime }}
KAROL BOMSZTYK其他文献
KAROL BOMSZTYK的其他文献
{{
              item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
{{ truncateString('KAROL BOMSZTYK', 18)}}的其他基金
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
预分析因素对球母细胞瘤 MGMT 启动子甲基化生物标志物测定的影响
- 批准号:9975358 
- 财政年份:2020
- 资助金额:$ 23.31万 
- 项目类别:
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
预分析因素对球母细胞瘤 MGMT 启动子甲基化生物标志物测定的影响
- 批准号:10415839 
- 财政年份:2020
- 资助金额:$ 23.31万 
- 项目类别:
Transcriptional and epigenetic control of angiogenic genes in sepsis-induced acute kidney injury.
脓毒症引起的急性肾损伤中血管生成基因的转录和表观遗传控制。
- 批准号:9173657 
- 财政年份:2016
- 资助金额:$ 23.31万 
- 项目类别:
Transcriptional and epigenetic control of angiogenic genes in sepsis-induced acute kidney injury.
脓毒症引起的急性肾损伤中血管生成基因的转录和表观遗传控制。
- 批准号:9334850 
- 财政年份:2016
- 资助金额:$ 23.31万 
- 项目类别:
Integrated microplate platform for epigenetic analysis
用于表观遗传分析的集成微孔板平台
- 批准号:9066225 
- 财政年份:2014
- 资助金额:$ 23.31万 
- 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
- 批准号:8118789 
- 财政年份:2010
- 资助金额:$ 23.31万 
- 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
- 批准号:8305648 
- 财政年份:2010
- 资助金额:$ 23.31万 
- 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
- 批准号:8541828 
- 财政年份:2010
- 资助金额:$ 23.31万 
- 项目类别:
Acute Renal Failure: An Endotoxin Hyper-Responsive State
急性肾衰竭:内毒素高反应状态
- 批准号:7982459 
- 财政年份:2010
- 资助金额:$ 23.31万 
- 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:10073243 
- 财政年份:2024
- 资助金额:$ 23.31万 
- 项目类别:Knowledge Transfer Partnership 
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:10752129 
- 财政年份:2024
- 资助金额:$ 23.31万 
- 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:2339201 
- 财政年份:2024
- 资助金额:$ 23.31万 
- 项目类别:Continuing Grant 
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:MR/Y008693/1 
- 财政年份:2024
- 资助金额:$ 23.31万 
- 项目类别:Research Grant 
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:10076445 
- 财政年份:2023
- 资助金额:$ 23.31万 
- 项目类别:Grant for R&D 
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:23K14783 
- 财政年份:2023
- 资助金额:$ 23.31万 
- 项目类别:Grant-in-Aid for Early-Career Scientists 
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:23KJ0394 
- 财政年份:2023
- 资助金额:$ 23.31万 
- 项目类别:Grant-in-Aid for JSPS Fellows 
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:10639161 
- 财政年份:2023
- 资助金额:$ 23.31万 
- 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:10752441 
- 财政年份:2023
- 资助金额:$ 23.31万 
- 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:10867639 
- 财政年份:2023
- 资助金额:$ 23.31万 
- 项目类别:

 刷新
              刷新
            
















 {{item.name}}会员
              {{item.name}}会员
            



